Elsevier BV

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Chimonas
    Chimonas
  3. Feldman
    Feldman
  4. Knezevic
    Knezevic
  5. Mao
    Mao
  6. Adusumilli
    Adusumilli
  7. Aggen
    Aggen
  8. Baky
    Baky
  9. Baser
    Baser
  10. Benfante
    Benfante

Groups

  1. Department of Medicine (7)
  2. Population Sciences Research Program (7)
  3. Epidemiology and Biostatistics (6)
  4. Sloan Kettering Institute Postdocs (5)
  5. Graduate Medical Education (4)
  6. Solid Tumor Oncology Division (4)
  7. Surgery (4)
  8. Department of Pathology and Laboratory Medicine (3)
  9. Health Outcomes Research Group (3)
  10. Hematologic Malignancies, Division of (3)
Search Within
  1. "2024"
Formats
  1. Journal Article (16)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (7)
  2. Population Sciences Research Program (7)
  3. Epidemiology and Biostatistics (6)
  4. Sloan Kettering Institute Postdocs (5)
  5. Graduate Medical Education (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Andrew Vickers (3)
  2. Andrea Knezevic (2)
  3. Darren Feldman (2)
  4. Jun Mao (2)
  5. Susan Chimonas (2)
  6. Xiaotong Li (2)

More People

Years
  1. 2024 (18)
Publications
  1. European Urology Oncology (4)
  2. JTO Clinical and Research Reports (3)
  3. European Urology Open Science (2)
  4. Integrative Medicine Research (2)
  5. Journal of Cancer Policy (2)
  6. Bioelectrochemistry (1)

More Publications

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of baseline prostate-specific antigen value prior to age 60 in predicting lethal prostate cancer: Analysis of a contemporary North American cohort
    Journal Article

    Finati, M.; Davis, M.; Stephens, A.; Chiarelli, G.; Cirulli, G. O.; Morrison, C.; Affas, R.; Sood, A.; Buffi, N.; Lughezzani, G.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Realizing the scope of venous and arterial thrombosis in cyclin-dependent kinase 4/6 inhibitors in hormone positive breast cancer
    Editorial

    Wilkins, C. R.; Zwicker, J. I.
    European Journal of Internal Medicine (2024)

    Fulltext@MSK | Save
  • FITM2 deficiency results in ER lipid accumulation, ER stress, and reduced apolipoprotein B lipidation and VLDL triglyceride secretion in vitro and in mouse liver
    Journal Article

    Wang, H.; Nikain, C.; Fortounas, K. I.; Amengual, J.; Tufanli, O.; La Forest, M.; Yu, Y.; Wang, M. C.; Watts, R.; Lehner, R.; more...
    Molecular Metabolism (2024)

    Fulltext@MSK | Save
  • The out-of-pocket cost of breast cancer care in Nigeria: A prospective analysis
    Journal Article

    Wuraola, F. O.; Blackman, C.; Olasehinde, O.; Aderounmu, A. A.; Adeleye, A.; Omoyiola, O. Z.; Kingham, T. P.; Fodero, R. F.; Adisa, A. O.; Lumati, J.; more...
    Journal of Cancer Policy (2024)

    Fulltext@MSK | Save
  • Symptom improvements and adverse effects with Reishi mushroom use: A cross-sectional survey of cancer patients
    Journal Article

    Li, X.; Sun, L.; Chimonas, S.; Li, S. Q.; Feng, P.; Yang, Y.; Mao, J. J.
    Integrative Medicine Research (2024)

    Fulltext@MSK | Save
  • ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in ALK-positive NSCLC with prior ALK inhibitor resistance
    Journal Article

    Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Three-year overall survival outcomes and correlative analyses in patients with NSCLC and high (50%–89%) versus very high (≥90%) programmed death-ligand 1 expression treated with first-line pembrolizumab or cemiplimab
    Journal Article

    Ricciuti, B.; Elkrief, A.; Lin, J.; Zhang, J.; Alessi, J. V.; Lamberti, G.; Gandhi, M.; Di Federico, A.; Pecci, F.; Wang, X.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Oncologic outcomes of incidental versus biopsy-diagnosed grade group 1 prostate cancer: A multi-institutional study
    Journal Article

    Leni, R.; Vertosick, E. A.; van den Bergh, R. C. N.; Soeterik, T. F. W.; Heetman, J. G.; van Melick, H. H. E.; Roscigno, M.; La Croce, G.; Da Pozzo, L. F.; Olivier, J.; more...
    European Urology Open Science (2024)

    Fulltext@MSK | Save
  • Perioperative serum microRNA 371a-3p and 372-3p levels in patients with clinically localized testicular masses
    Journal Article

    Matulewicz, R. S.; Baky, F.; Knezevic, A.; Sheinfeld, J.; Williams, B. M.; Kantor, R. E.; Liso, N.; Hossain, J.; Bromberg, M.; Valentino, A.; more...
    European Urology Open Science (2024)

    Fulltext@MSK | Save
  • Positive surgical margins after anterior robot-assisted radical prostatectomy: Assessing the learning curve in a multi-institutional collaboration
    Journal Article

    Bravi, C. A.; Dell'Oglio, P.; Piazza, P.; Scarcella, S.; Bianchi, L.; Falagario, U.; Turri, F.; Andras, I.; Di Maida, F.; De Groote, R.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save

    • Elsevier BV – authorized name for: